Importantly, the relative contributions of tumor intrinsic and tumor-extrinsic STING activation leading to type I IFN production, and how that IFN production relates to tumor microenvironment inflammation and induction of productive anti-tumor immune responses, has not been well defined. This evidence concerns the gene STING1 and neoplasm.